Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Invested Capital (2020 - 2025)

Historic Invested Capital for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to -$3.1 million.

  • Bio Essence's Invested Capital fell 545.48% to -$3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 545.48%. This contributed to the annual value of -$3.0 million for FY2024, which is 7926.55% down from last year.
  • As of Q3 2025, Bio Essence's Invested Capital stood at -$3.1 million, which was down 545.48% from -$3.1 million recorded in Q2 2025.
  • Over the past 5 years, Bio Essence's Invested Capital peaked at $883.7 million during Q3 2021, and registered a low of -$3.4 million during Q1 2023.
  • For the 5-year period, Bio Essence's Invested Capital averaged around $44.3 million, with its median value being -$2.7 million (2022).
  • In the last 5 years, Bio Essence's Invested Capital skyrocketed by 5233730.35% in 2021 and then crashed by 189208.59% in 2022.
  • Over the past 5 years, Bio Essence's Invested Capital (Quarter) stood at -$2.4 million in 2021, then plummeted by 33.62% to -$3.2 million in 2022, then soared by 48.71% to -$1.7 million in 2023, then tumbled by 79.27% to -$3.0 million in 2024, then fell by 4.48% to -$3.1 million in 2025.
  • Its Invested Capital was -$3.1 million in Q3 2025, compared to -$3.1 million in Q2 2025 and -$3.2 million in Q1 2025.